The Pharma Data

DECEMBER 17, 2020

Doctor Johnson has had an inspiring career that encompasses several aspects of the pharmacy industry. Doctor Johnson aspires to incorporate the latest technologies available in healthcare to care for her patients. Subsequently, she decided to pursue a higher education in pharmacology following her high school graduation.

Pharmacy 52

Pharmacy Doctors Hospitals DNA 52

Agency IQ

SEPTEMBER 15, 2023

FDA’s nonprescription advisors find no efficacy for phenylephrine This week, FDA’s Nonprescription Drugs Advisory Committee (NDAC) voted unanimously that current scientific data do not support the efficacy of oral phenylephrine as a nasal decongestant, aligning with FDA analysis — and re-analysis — of data.

Science 40

Science FDA Clinical Trials Pharmacy 40

Drug & Device Law

MAY 19, 2023

Over the past few months, Bexis, with the substantial help of several Reed Smith associates, has prepared a law review article – “Federal Preemption and the Post- Dobbs Reproductive Freedom Frontier” – which will soon be published in the Food & Drug Law Journal. A draft of this article is now available on SSRN. In GenBioPro, Inc.

FDA Approval 111

FDA Approval Pharmacy FDA Production 111

Drug & Device Law

MAY 26, 2023

In that case, the Fourth Circuit knocked out a Maryland law designed to prevent price gouging on drugs because of its extraterritorial reach. Since Bartlett (and in some cases before it), stop selling claims as to NDA and ANDA drugs have been widely preempted. Prescription drugs are not. See here.

Regulations 59

Regulations Production FDA FDA Approval 59

Drug & Device Law

OCTOBER 26, 2023

Recently, within the course of a couple of weeks, two different courts reached the same conclusion – that a plaintiff’s negligence per se claims, largely based on purported violations of the Food, Drug & Cosmetic Act (“FDCA”), failed to state a claim. See Disarro v. Ezricare, LLC , 2023 WL 6619445 (M.D. 11, 2023), and Alcozar v.

Regulations 59

Regulations Doctors FDA Drugs 59